ArticleDrug design, development and therapy2016

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.

Jing Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.